Targeted Oncology |
Mesa Discusses the Management of Patients With Polycythemia Vera in 2 Case Studies
Targeted Oncology With newly diagnosed patients with PV, universally we would use a control of the hematocrit through at least phlebotomy to [get to a] hematocrit of under 45%. That has been shown to be helpful in randomized clinical trials. Next, barring an aspirin ... |
from phlebotomy - Google News http://bit.ly/2qE5XGZ
No comments:
Post a Comment